Learn / AMLX
NASDAQ: AMLX
Amylyx Pharmaceuticals (AMLX) stock, explained like you're 5
Amylyx Pharmaceuticals trades on the Nasdaq under the ticker AMLX. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 3.5 billion dollars.
- Ticker
- AMLX
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Mid cap, about 3.5 billion dollars
Is Amylyx Pharmaceuticals a small, medium or large cap company?
No. Amylyx Pharmaceuticals is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 3.5 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Amylyx Pharmaceuticals makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves AMLX stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Why Is AMLX Stock Popping 14% After Hours? (Stocktwits)
- AMLX Stock Heads For Best Day In Nearly Four Years Retail Sees Near 70% Upside Potential From Current Levels (Stocktwits)
- Will Phase 3 Trial Data Change Amylyx Pharmaceuticals Stock Narrative (Simply Wall Street)
- Amylyx Pharmaceuticals, Inc. Stock 12‑Month Price Target Raised to $43, Implies 59% Upside (TradingView)
- Why Amylyx Pharmaceuticals Stock Skyrocketed Today (Yahoo Finance)
Follow AMLX in your daily brief
Each trading day at 5 PM ET we post what happened to Amylyx Pharmaceuticals and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow AMLX
Questions about Amylyx Pharmaceuticals stock
What does Amylyx Pharmaceuticals do?
Amylyx Pharmaceuticals trades on the Nasdaq under the ticker AMLX. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 3.5 billion dollars.
What is the ticker symbol for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals trades under the ticker AMLX on the Nasdaq.
What is Amylyx Pharmaceuticals's market cap?
Amylyx Pharmaceuticals is a mid cap stock with a market cap of about 3.5 billion dollars.
How does Amylyx Pharmaceuticals make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves AMLX stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow AMLX stock every day?
Add AMLX to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.